How has Pfizer impacted global health and medicine since COVID-19? The company鈥檚 chairman and CEO, Dr. Albert Bourla, offers his thoughts in this new video. Bourla earned a 2022 Double Helix Medal for spearheading the rapid development of Pfizer鈥檚 COVID-19 vaccine.
Since taking over at Pfizer, he has worked to accelerate the company鈥檚 transformation to a more science-driven, innovative organization. Bourla sold off the company鈥檚 consumer and non-patent products businesses to focus Pfizer鈥檚 resources on research and development. He then created a 鈥淧urpose Blueprint鈥� to guide how those resources were used.
Two years later, Bourla issued the biopharmaceutical industry鈥檚 first sustainability bond. The bond helps make Pfizer鈥檚 medicines and vaccines available to more patients. It also helps reduce the company鈥檚 environmental impact.
Under his leadership, Pfizer has committed to educating the next generation of scientists. The pharmaceutical giant partnered with CSHL鈥檚 DNA Learning Center to expand the reach of its hands-on science programs to more students in underfunded school districts.
Find out more about Pfizer鈥檚 work and Dr. Bourla鈥檚 vision for public health in the video above.
Read the related story: 17th CSHL Double Helix Medals dinner raises $5.8 million